Published in Clin Sci (Lond) on January 01, 1986
A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest (1986) 1.54
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
Lung collagen: more than scaffolding. Thorax (1986) 1.19
Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. Thorax (1993) 1.03
Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis. Thorax (1990) 0.85
Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation. J Biol Chem (2014) 0.83
Second harmonic generation microscopy analysis of extracellular matrix changes in human idiopathic pulmonary fibrosis. J Biomed Opt (2014) 0.80
What is pulmonary fibrosis? Thorax (1988) 0.75
Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis. Oncoimmunology (2015) 0.75
On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest (1977) 6.54
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax (1980) 3.70
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies. Clin Allergy (1971) 2.71
Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J (1970) 2.67
Nocturnal asthma: a study in general practice. J R Coll Gen Pract (1989) 2.55
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J (2007) 2.47
Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax (1993) 2.33
Cryptogenic fibrosing alveolitis and lung cancer. Thorax (1980) 2.31
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. Thorax (1975) 2.28
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax (1980) 2.27
A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci (1989) 2.17
Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax (2000) 2.16
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) (2001) 2.16
Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol (1997) 2.09
Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol (2001) 1.96
Fibrosing alveolitis and chronic liver disease. Q J Med (1968) 1.91
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax (1980) 1.82
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis (1981) 1.76
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax (1989) 1.75
Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med (1990) 1.71
Short stature, mental retardation, and hypoparathyroidism: a new syndrome. Arch Dis Child (1990) 1.70
Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol (1997) 1.70
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
The effects of antigens and of phytohemagglutinin on rabbit spleen cell suspensions. J Exp Med (1966) 1.66
Pulmonary fibrosis: cytokines in the balance. Eur Respir J (1998) 1.64
Pulmonary haemosiderosis and pulmonary haemorrhage. Br J Dis Chest (1981) 1.56
Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med (2000) 1.55
Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology (1994) 1.54
Aspergillus fumigatus and lung disease. Postgrad Med J (1979) 1.52
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol (2000) 1.52
High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis (1976) 1.51
Chronic bronchial suppuration and inflammatory bowel disease. Q J Med (1981) 1.50
Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol (1978) 1.50
Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. Br J Dis Chest (1981) 1.49
Rhizomelic chondrodysplasia punctata with isolated DHAP-AT deficiency. Arch Dis Child (1993) 1.47
Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies. Clin Allergy (1971) 1.47
Turnover of muscle protein in the fowl. Changes in rates of protein synthesis and breakdown during hypertrophy of the anterior and posterior latissimus dorsi muscles. Biochem J (1978) 1.47
Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet (1982) 1.45
Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev (1988) 1.44
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med (2000) 1.44
The British Thoracic Society. Thorax (1982) 1.42
Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol (1987) 1.42
Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem (2000) 1.41
Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis (1991) 1.41
Pulmonary disease in Behçet's syndrome. Q J Med (1986) 1.39
Circulating antinuclear antibody and rheumatoid factor in coal pneumoconiosis. Br Med J (1974) 1.39
Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Thorax (1983) 1.39
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
Nedocromil sodium workshop. Respir Med (1989) 1.38
Computed tomography in adult obliterative bronchiolitis. Clin Radiol (1990) 1.38
Turnover of muscle protein in the fowl (Gallus domesticus). Rates of protein synthesis in fast and slow skeletal, cardiac and smooth muscle of the adult fowl. Biochem J (1978) 1.35
Presence and distribution of sensory nerve fibers in human peritoneal adhesions. Ann Surg (2001) 1.33
Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax (1979) 1.33
Ultrastructural changes in bronchoalveolar lavage cells in sarcoidosis and comparison with the tissue granuloma. Am J Pathol (1983) 1.31
Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol (2001) 1.31
Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia. Clin Exp Immunol (1976) 1.28
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax (1983) 1.28
Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol (1985) 1.28
Rates of collagen synthesis in lung, skin and muscle obtained in vivo by a simplified method using [3H]proline. Biochem J (1982) 1.26
Turnover of muscle protein in the fowl. Collagen content and turnover in cardiac and skeletal muscles of the adult fowl and the changes during stretch-induced growth. Biochem J (1978) 1.26
Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol (1985) 1.25
A case of pulmonary veno-occlusive disease respondong to treatment with azathioprine. Thorax (1977) 1.24
The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? Int J Biochem Cell Biol (1997) 1.24
Diagnosis and management of alveolar proteinosis: the rôle of electron microscopy. Thorax (1975) 1.23
Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J (1998) 1.23
Factors influencing the prevalence of asthma among first degree relatives of extrinsic and intrinsic asthmatics. Thorax (1979) 1.22
Pulmonary veno-occlusion--an immune complex disease? Virchows Arch A Pathol Anat Histol (1974) 1.21
Smooth muscle antibody in bronchial asthma. Clin Exp Immunol (1970) 1.20
The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis (1987) 1.20
Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem J (1991) 1.19
Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J (1997) 1.19
Lung collagen: more than scaffolding. Thorax (1986) 1.19
Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax (1981) 1.18
A simplified method for quantitation of the relative amounts of type I and type III collagen in small tissue samples. Anal Biochem (1981) 1.18
Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax (2001) 1.18
Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs. Proc R Soc Med (1974) 1.17
The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs. Q J Med (1971) 1.17
Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol (1994) 1.16
Biochemical and histological changes in pulmonary fibrosis induced in rabbits with intratracheal bleomycin. Eur J Clin Invest (1981) 1.15
Collagen turnover and its regulation in the normal and hypertrophying heart. Eur Heart J (1995) 1.15
Reversed anaphylactic reaction of leucocytes in intrinsic asthma. Clin Allergy (1971) 1.14
Assay of circulating immunoglobulins in patients with fibrosing alveolitis. Clin Exp Immunol (1967) 1.14
Radiographic progression of asbestosis: preliminary report. Ann N Y Acad Sci (1979) 1.14
Outcome in tyrosinaemia type II. Arch Dis Child (1991) 1.13
The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J (2002) 1.13
Cryptogenic pulmonary eosinophilia. Clin Allergy (1976) 1.11
Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med (1989) 1.11
Autoantibodies in iodide goitre and asthma. Clin Exp Immunol (1966) 1.10
Breath sounds in emphysema. Br J Dis Chest (1969) 1.10
Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat. Coll Relat Res (1987) 1.10
Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen. Am Rev Respir Dis (1983) 1.10
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax (1984) 1.08
Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases. Am Rev Respir Dis (1987) 1.08
Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans (2002) 1.07
Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysis. Arch Environ Health (1986) 1.07